Summary of findings: pioglitazone monotherapy vs another pharmacological glucose‐lowering monotherapy
Serious adverse events (N) · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
- Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found